Blog

Washington, D.C. (October 14, 2025) — A new study led by researchers at the George Washington University and published through the DC Cohort, one of the largest HIV longitudinal studies in the United States, finds that nearly half of people…

A new study published in Nature’s Scientific Reports indicates that amyotrophic lateral sclerosis (ALS) and multiple sclerosis (MS) have an extremely high geographic association, even after controlling for race, gender, wealth,…

In recent years, the landscape of antiretroviral therapy (ART) for HIV has undergone significant transformations, largely driven by the introduction of more effective and safer drug options. Among these, two formulations of tenofovir, namely…

Lenacapavir, a long-acting injectable administered once every six months, could be a component of combination regimens for people starting HIV treatment for the first time, according to final results from the CALIBRATE study. After 132 weeks of…

The Lancet On Sept 4, 2025, DR Congo declared its 16th Ebola virus outbreak. The epicentre of this outbreak occurred in the Kasai province—the first resurgence in this region since 2008.¹ Genomic analysis identified an Ebola virus with more…